77 related articles for article (PubMed ID: 21664731)
41. Biological activities of some 1,2,4-triazoles and 1,2,4-triazolin-5-ones.
Ikízler A; Gümüs F; Ozden S; Abbasoğlu U
Pharmazie; 1989 Jul; 44(7):506-7. PubMed ID: 2510189
[No Abstract] [Full Text] [Related]
42. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
43. Conventional and microwave assisted synthesis of 2-oxo-4-substituted aryl-azetidine derivatives of benzotriazole: a new class of biological compounds.
Dubey A; Srivastava SK; Srivastava SD
Bioorg Med Chem Lett; 2011 Jan; 21(1):569-73. PubMed ID: 21130647
[TBL] [Abstract][Full Text] [Related]
44. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
Jadhav GR; Shaikh MU; Kale RP; Shiradkar MR; Gill CH
Eur J Med Chem; 2009 Jul; 44(7):2930-5. PubMed ID: 19150154
[TBL] [Abstract][Full Text] [Related]
45. New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents.
Thomas KD; Adhikari AV; Chowdhury IH; Sumesh E; Pal NK
Eur J Med Chem; 2011 Jun; 46(6):2503-12. PubMed ID: 21489660
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity.
Demaray JA; Thuener JE; Dawson MN; Sucheck SJ
Bioorg Med Chem Lett; 2008 Sep; 18(17):4868-71. PubMed ID: 18678487
[TBL] [Abstract][Full Text] [Related]
48. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
[TBL] [Abstract][Full Text] [Related]
49. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642
[TBL] [Abstract][Full Text] [Related]
50. Oxadiazole mannich bases: synthesis and antimycobacterial activity.
Ali MA; Shaharyar M
Bioorg Med Chem Lett; 2007 Jun; 17(12):3314-6. PubMed ID: 17467984
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of some 4-(alkylidene/arylidene)amino-2,4-dihydro-5- (2-thienyl)-3H-1,2,4-triazole-3-thiones tested for antimicrobial activity.
Ulusoy N; Ergenç N; Otük G; Kiraz M
Boll Chim Farm; 2001; 140(6):417-21. PubMed ID: 11822231
[TBL] [Abstract][Full Text] [Related]
53. 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.
Moshafi MH; Sorkhi M; Emami S; Nakhjiri M; Yahya-Meymandi A; Negahbani AS; Siavoshi F; Omrani M; Alipour E; Vosooghi M; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2011 Mar; 344(3):178-83. PubMed ID: 21384417
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Liu P; Zhu S; Li P; Xie W; Jin Y; Sun Q; Wu Q; Sun P; Zhang Y; Yang X; Jiang Y; Zhang D
Bioorg Med Chem Lett; 2008 Jun; 18(11):3261-5. PubMed ID: 18467095
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents.
Küçükgüzel I; Tatar E; Küçükgüzel SG; Rollas S; De Clercq E
Eur J Med Chem; 2008 Feb; 43(2):381-92. PubMed ID: 17583388
[TBL] [Abstract][Full Text] [Related]
57. Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.
Xu ZQ; Pupek K; Suling WJ; Enache L; Flavin MT
Bioorg Med Chem; 2006 Jul; 14(13):4610-26. PubMed ID: 16513358
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purines.
Read ML; Braendvang M; Miranda PO; Gundersen LL
Bioorg Med Chem; 2010 Jun; 18(11):3885-97. PubMed ID: 20488716
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
[TBL] [Abstract][Full Text] [Related]
60. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis.
Manjunatha UH; Boshoff H; Dowd CS; Zhang L; Albert TJ; Norton JE; Daniels L; Dick T; Pang SS; Barry CE
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):431-6. PubMed ID: 16387854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
